Cheryl A Thompson. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Aryl Hydrocarbon Hydroxylases/geneticsCytochrome P-450 CYP2C9Drug LabelingGenetic VariationHumansMixed Function Oxygenases/geneticsPharmacogeneticsUnited StatesUnited States Food and Drug AdministrationVitamin K Epoxide ReductasesWarfarin/administration & dosage
Substances: See more » WarfarinMixed Function OxygenasesCYP2C9 protein, humanCytochrome P-450 CYP2C9Aryl Hydrocarbon HydroxylasesVitamin K Epoxide Reductases
Year: 2007 PMID: 17893404 DOI: 10.2146/news070085
Source DB: PubMed Journal: Am J Health Syst Pharm ISSN: 1079-2082 Impact factor: 2.637